ARS Pharmaceuticals, Inc

Stock Chart, Company Information, and Scan Results

$17.18(as of Aug 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

ARS Pharmaceuticals, Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$17.18
Ticker SymbolSPRY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees155
CountyUSA
Market Cap$1,736.4M
EBIDTA-26.7M
10-Day Moving Average17.81
P/E Ratio-107.65
20-Day Moving Average17.76
Forward P/E Ratio0.00
50-Day Moving Average16.36
Earnings per Share-0.16
200-Day Moving Average13.95
Profit Margin-425.69%
RSI48.47
Shares Outstanding98.2M
ATR0.74
52-Week High18.90
Volume1,181,354
52-Week Low8.91
Most Recent Support Level17.70
Book Value229.0M
Most Recent Resistance Level18.63
P/B Ratio7.36
Upper Keltner19.43
P/S Ratio17.35
Lower Keltner16.09
Debt-to-Equity Ratio19.43
Next Earnings Date08/06/2025
Cash Surplus12.2M
Next Ex-Dividend DateUnknown

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

ARS Pharmaceuticals, Inc In Our Stock Scanner

As of Aug 01, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.